Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CO › Alamosa › NPI 1568627941
Clinic

Valley-Wide Health Systems, INC

Valley-Wide Health Systems, INC was paid $10.76M by Medicaid between Jan 2018 and Nov 2024, across 27 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 80% of everything it billed.

33Billing provider infoVALLEY-WIDE HEALTH SYSTEMS, INC
ALAMOSA, CO 81101
33aNPI1568627941assigned 07/24/2008
28Total paid$10.76M
24GClaims75,573
24DCodes billed27
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Federally Qualified Health Center (FQHC) providers in Colorado

Rank by total paid#32 of 197
Median peer was paid$1.11M
This provider vs. median9.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official ARNOLDI, JANIA controls 19+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201812,333$1.45M
201912,840$1.52M
20208,885$1.01M
20218,822$1.27M
202211,064$1.84M
202312,786$2.27M
2024incomplete8,843$1.40M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 80% 37,945 36,171 $8.65M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 10% 4,613 4,481 $1.11M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 5.5% 2,540 2,454 $587K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 2.6% 1,160 1,123 $282K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 432 416 $88K
G0467 Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit <1% 577 536 $17K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,996 2,522 $11K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 46 46 $5K
99000 <1% 5,727 5,301 $2K
G8510 Screening for depression is documented as negative, a follow-up plan is not required <1% 1,181 1,161 $625.90
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 0% 4,701 4,594 $0.00
81002 0% 3,550 3,405 $0.00
15 more codes
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 0% 6,861 $0.00
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 0% 13 $0.00
81025 0% 170 $0.00
69209 0% 20 $0.00
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 0% 71 $0.00
J1885 Injection, ketorolac tromethamine, per 15 mg 0% 769 $0.00
J1100 Injection, dexamethasone sodium phosphate, 1 mg 0% 366 $0.00
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 0% 241 $0.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 0% 375 $0.00
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 0% 148 $0.00
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 0% 675 $0.00
87807 0% 263 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 0% 30 $0.00
G8433 Screening for depression not completed, documented patient or medical reason 0% 85 $0.00
90686 0% 18 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialARNOLDI, JANIA (PRESIDENT/CEO)
Same official

Other billing entities under ARNOLDI, JANIA

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.